Works by Lin, Ruitao

Results: 47

Nonparametric overdose control with late-onset toxicity in phase I clinical trials.

Published in:

2017

By:

RUITAO LIN;
GUOSHENG YIN;
Lin, Ruitao;
Yin, Guosheng

Publication type:

journal article

Bayesian optimal interval design for dose finding in drug-combination trials.

Published in:

2017

By:

Ruitao Lin;
Guosheng Yin;
Lin, Ruitao;
Yin, Guosheng

Publication type:

journal article

Identification of Key Elements in Prostate Cancer for Ontology Building via a Multidisciplinary Consensus Agreement.

Published in:

Cancers, 2023, v. 15, n. 12, p. 3121, doi. 10.3390/cancers15123121

By:

Moreno, Amy;
Solanki, Abhishek A.;
Xu, Tianlin;
Lin, Ruitao;
Palta, Jatinder;
Daugherty, Emily;
Hong, David;
Hong, Julian;
Kamran, Sophia C.;
Katsoulakis, Evangelia;
Brock, Kristy;
Feng, Mary;
Fuller, Clifton;
Mayo, Charles;
Consortium, BDSC Prostate Cancer

Publication type:

Article

Comb-BOIN12: A Utility-Based Bayesian Optimal Interval Design for Dose Optimization in Cancer Drug-Combination Trials.

Published in:

Statistics in Biopharmaceutical Research, 2025, v. 17, n. 2, p. 266, doi. 10.1080/19466315.2024.2370403

By:

Lu, Mengyi;
Zhang, Jingyi;
Yuan, Ying;
Lin, Ruitao

Publication type:

Article

Isotonic Phase I Cancer Clinical Trial Design Utilizing Patient-Reported Outcomes.

Published in:

Statistics in Biopharmaceutical Research, 2025, v. 17, n. 1, p. 36, doi. 10.1080/19466315.2023.2288013

By:

Wages, Nolan A.;
Lin, Ruitao

Publication type:

Article

Bayesian Optimal Designs for Multi-Arm Multi-Stage Phase II Randomized Clinical Trials with Multiple Endpoints.

Published in:

Statistics in Biopharmaceutical Research, 2024, v. 16, n. 3, p. 315, doi. 10.1080/19466315.2024.2344543

By:

Mulier, Guillaume;
Chevret, Sylvie;
Lin, Ruitao;
Biard, Lucie

Publication type:

Article

Design Strategy and Consideration for Oncology Dose-Optimization: An Industry Perspective.

Published in:

Statistics in Biopharmaceutical Research, 2024, v. 16, n. 3, p. 338, doi. 10.1080/19466315.2024.2332650

By:

Liu, Rong;
Yuan, Ying;
Sen, Suman;
Marchenko, Olga;
Jiang, Qi;
Tian, Hong;
Li, Xiaoyun;
Lin, Ruitao;
Lu, Cindy;
Zhou, Heng

Publication type:

Article

Accuracy and Safety of Novel Designs for Phase I Drug-Combination Oncology Trials.

Published in:

Statistics in Biopharmaceutical Research, 2022, v. 14, n. 3, p. 270, doi. 10.1080/19466315.2022.2081602

By:

Liu, Rong;
Yuan, Ying;
Sen, Suman;
Yang, Xin;
Jiang, Qi;
Li, Xiaoyun;
Lu, Chengxing;
Gönen, Mithat;
Tian, Hong;
Zhou, Heng;
Lin, Ruitao;
Marchenko, Olga

Publication type:

Article

BAGS: A Bayesian Adaptive Group Sequential Trial Design With Subgroup-Specific Survival Comparisons.

Published in:

Journal of the American Statistical Association, 2021, v. 116, n. 533, p. 322, doi. 10.1080/01621459.2020.1837142

By:

Lin, Ruitao;
Thall, Peter F.;
Yuan, Ying

Publication type:

Article

A Generalized Phase I/II Dose Optimization Trial Design With Multi‐Categorical and Multi‐Graded Outcomes.

Published in:

Statistics in Medicine, 2025, v. 44, n. 7, p. 1, doi. 10.1002/sim.70049

By:

Yan, Yichen;
Lin, Ruitao;
Guan, Tianyu;
Shi, Haolun;
Lin, Xiaolei

Publication type:

Article

REDOMA: Bayesian random‐effects dose‐optimization meta‐analysis using spike‐and‐slab priors.

Published in:

Statistics in Medicine, 2024, v. 43, n. 18, p. 3484, doi. 10.1002/sim.10107

By:

Yang, Cheng‐Han;
Kwiatkowski, Evan;
Lee, J. Jack;
Lin, Ruitao

Publication type:

Article

Design and sample size determination for multiple‐dose randomized phase II trials for dose optimization.

Published in:

Statistics in Medicine, 2024, v. 43, n. 15, p. 2972, doi. 10.1002/sim.10093

By:

Yang, Peng;
Li, Daniel;
Lin, Ruitao;
Huang, Bo;
Yuan, Ying

Publication type:

Article

BOB: Bayesian optimal design for biosimilar trials with co‐primary endpoints.

Published in:

Statistics in Medicine, 2022, v. 41, n. 26, p. 5319, doi. 10.1002/sim.9571

By:

Chi, Xiaohan;
Yu, Zhangsheng;
Lin, Ruitao

Publication type:

Article

TITE‐BOIN12: A Bayesian phase I/II trial design to find the optimal biological dose with late‐onset toxicity and efficacy.

Published in:

Statistics in Medicine, 2022, v. 41, n. 11, p. 1918, doi. 10.1002/sim.9337

By:

Zhou, Yanhong;
Lin, Ruitao;
Lee, J. Jack;
Li, Daniel;
Wang, Li;
Li, Ruobing;
Yuan, Ying

Publication type:

Article

uTPI: A utility-based toxicity probability interval design for phase I/II dose-finding trials.

Published in:

2021

By:

Shi, Haolun;
Cao, Jiguo;
Yuan, Ying;
Lin, Ruitao

Publication type:

journal article

STEIN: A simple toxicity and efficacy interval design for seamless phase I/II clinical trials.

Published in:

2017

By:

Lin, Ruitao;
Yin, Guosheng

Publication type:

journal article

Denitrification-induced carbonate precipitation by bio-composite material with Pseudomonas aeruginosa for simultaneous nitrate and cadmium remediation.

Published in:

Human & Ecological Risk Assessment, 2023, v. 29, n. 2, p. 494, doi. 10.1080/10807039.2022.2134092

By:

Fang, Chaolin;
Lin, Ruitao;
Xu, Kaixuan;
Achal, Varenyam

Publication type:

Article

Non‐parametric overdose control for dose finding in drug combination trials.

Published in:

Journal of the Royal Statistical Society: Series C (Applied Statistics), 2019, v. 68, n. 4, p. 1111, doi. 10.1111/rssc.12349

By:

Lam, Chi Kin;
Lin, Ruitao;
Yin, Guosheng

Publication type:

Article

Real-World Effectiveness of Chemoimmunotherapy and Novel Therapies for Patients With Relapsed/Refractory Aggressive Large B-Cell Lymphoma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 4, p. e183, doi. 10.1016/j.clml.2024.11.014

By:

Nastoupil, Loretta J.;
Andersen, Clark R.;
Ayers, Amy;
Yucai Wang;
Habermann, Thomas M.;
Dai Chihara;
Kahl, Brad S.;
Link, Brian K.;
Koff, Jean L.;
Cohen, Jonathon B.;
Martin, Peter;
Lossos, Izidore S.;
Stanchina, Michele;
Haddadi, Sara;
Casulo, Carla;
Ayyappan, Sabarish;
Ruitao Lin;
Ziyi Li;
Larson, Melissa A.;
Maurer, Matthew J.

Publication type:

Article

The global, regional, and national burden of cancer among adolescents and young adults in 204 countries and territories, 1990–2019: a population-based study.

Published in:

Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01093-3

By:

Wen, Yi Feng;
Chen, Meng Xuan;
Yin, Guosheng;
Lin, Ruitao;
Zhong, Yu Jie;
Dong, Qian Qian;
Wong, Hai Ming

Publication type:

Article

Quality assurance assessment of intra-acquisition diffusion-weighted and T2-weighted magnetic resonance imaging registration and contour propagation for head and neck cancer radiotherapy.

Published in:

Medical Physics, 2023, v. 50, n. 4, p. 2089, doi. 10.1002/mp.16128

By:

Naser, Mohamed A.;
Wahid, Kareem A.;
Ahmed, Sara;
Salama, Vivian;
Dede, Cem;
Edwards, Benjamin W.;
Ruitao Lin;
McDonald, Brigid;
Salzillo, Travis C.;
Renjie He;
Yao Ding;
Abdelaal, Moamen Abobakr;
Thill, Daniel;
O’Connell, Nicolette;
Willcut, Virgil;
Christodouleas, John P.;
Lai, Stephen Y.;
Fuller, Clifton D.;
Mohamed, Abdallah S. R.

Publication type:

Article

High-dimensional multivariate analysis of variance via geometric median and bootstrapping.

Published in:

Biometrics, 2024, v. 80, n. 3, p. 1, doi. 10.1093/biomtc/ujae088

By:

Cheng, Guanghui;
Lin, Ruitao;
Peng, Liuhua

Publication type:

Article

Signet ring cells and conditional survival after trimodality therapy for esophageal adenocarcinoma.

Published in:

Journal of Surgical Oncology, 2024, v. 130, n. 3, p. 428, doi. 10.1002/jso.27774

By:

Mitchell, Kyle G.;
Feldman, Hope;
Milton, Denái R.;
Antonoff, Mara B.;
Hofstetter, Wayne L.;
Rice, David C.;
Vaporciyan, Ara A.;
Lin, Ruitao;
Thall, Peter F.;
Rajaram, Ravi

Publication type:

Article

On the relative efficiency of model-assisted designs: a conditional approach.

Published in:

Journal of Biopharmaceutical Statistics, 2019, v. 29, n. 4, p. 648, doi. 10.1080/10543406.2019.1632881

By:

Lin, Ruitao;
Yuan, Ying

Publication type:

Article

TESTING HOMOGENEITY OF HIGH-DIMENSIONAL COVARIANCE MATRICES.

Published in:

Statistica Sinica, 2020, v. 30, n. 1, p. 35, doi. 10.5705/ss.202017.0275

By:

Shurong Zheng;
Ruitao Lin;
Jianhua Guo;
Guosheng Yin

Publication type:

Article

Adaptive Bayesian information borrowing methods for finding and optimizing subgroup-specific doses.

Published in:

Clinical Trials, 2024, v. 21, n. 3, p. 308, doi. 10.1177/17407745231212193

By:

Zhang, Jingyi;
Lin, Ruitao;
Chen, Xin;
Yan, Fangrong

Publication type:

Article

On the relative conservativeness of Bayesian logistic regression method in oncology dose‐finding studies.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 4, p. 585, doi. 10.1002/pst.2364

By:

Yang, Cheng‐Han;
Cheng, Guanghui;
Lin, Ruitao

Publication type:

Article

Bayesian single‐to‐double arm transition design using both short‐term and long‐term endpoints.

Published in:

Pharmaceutical Statistics, 2023, v. 22, n. 4, p. 588, doi. 10.1002/pst.2292

By:

Xu, Tianlin;
Shi, Haolun;
Lin, Ruitao

Publication type:

Article

The use of local and nonlocal priors in Bayesian test‐based monitoring for single‐arm phase II clinical trials.

Published in:

Pharmaceutical Statistics, 2021, v. 20, n. 6, p. 1183, doi. 10.1002/pst.2139

By:

Zhou, Yanhong;
Lin, Ruitao;
Lee, J. Jack

Publication type:

Article

Uniformly most powerful Bayesian interval design for phase I dose‐finding trials.

Published in:

Pharmaceutical Statistics, 2018, v. 17, n. 6, p. 710, doi. 10.1002/pst.1889

By:

Lin, Ruitao;
Yin, Guosheng

Publication type:

Article

A Phase I-II Basket Trial Design to Optimize Dose-Schedule Regimes Based on Delayed Outcomes.

Published in:

Bayesian Analysis, 2021, v. 16, n. 1, p. 179, doi. 10.1214/20-BA1205

By:

Ruitao Lin;
Thall, Peter F.;
Ying Yuan

Publication type:

Article

Trends and Patterns of Disparities in Burden of Lung Cancer in the United States, 1974-2015.

Published in:

Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00404

By:

Zhong, Yu Jie;
Wen, Yi Feng;
Wong, Hai Ming;
Yin, Guosheng;
Lin, Ruitao;
Yang, Shuan Ying

Publication type:

Article

Comments on 'Competing designs for drug combination in phase I dose-finding clinical trials' by M-K. Riviere, F. Dubois, and S. Zohar.

Published in:

Statistics in Medicine, 2015, v. 34, n. 1, p. 13, doi. 10.1002/sim.6338

By:

Yin, Guosheng;
Lin, Ruitao

Publication type:

Article

Bayesian adaptive model selection design for optimal biological dose finding in phase I/II clinical trials.

Published in:

Biostatistics, 2023, v. 24, n. 2, p. 277, doi. 10.1093/biostatistics/kxab028

By:

Lin, Ruitao;
Yin, Guosheng;
Shi, Haolun

Publication type:

Article

Time-to-event model-assisted designs for dose-finding trials with delayed toxicity.

Published in:

2020

By:

Lin, Ruitao;
Yuan, Ying

Publication type:

journal article

Inter-Ethnic/Racial Facial Variations: A Systematic Review and Bayesian Meta-Analysis of Photogrammetric Studies.

Published in:

PLoS ONE, 2015, v. 10, n. 8, p. 1, doi. 10.1371/journal.pone.0134525

By:

Wen, Yi Feng;
Wong, Hai Ming;
Lin, Ruitao;
Yin, Guosheng;
McGrath, Colman

Publication type:

Article

Discussion on "Predictively consistent prior effective sample sizes," by Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, and Anthony O'Hagan.

Published in:

Biometrics, 2020, v. 76, n. 2, p. 595, doi. 10.1111/biom.13246

By:

Park, Yeonhee;
Lin, Ruitao

Publication type:

Article

An adaptive trial design to optimize dose‐schedule regimes with delayed outcomes.

Published in:

Biometrics, 2020, v. 76, n. 1, p. 304, doi. 10.1111/biom.13116

By:

Lin, Ruitao;
Thall, Peter F.;
Yuan, Ying

Publication type:

Article

Bayesian optimal interval design with multiple toxicity constraints.

Published in:

Biometrics, 2018, v. 74, n. 4, p. 1320, doi. 10.1111/biom.12912

By:

Lin, Ruitao

Publication type:

Article

A Bayesian quasi-likelihood design for identifying the minimum effective dose and maximum utility dose in dose-ranging studies.

Published in:

Statistical Methods in Medical Research, 2024, v. 33, n. 6, p. 931, doi. 10.1177/09622802241239268

By:

Tian, Feng;
Lin, Ruitao;
Wang, Li;
Yuan, Ying

Publication type:

Article

Local continual reassessment methods for dose finding and optimization in drug-combination trials.

Published in:

Statistical Methods in Medical Research, 2023, v. 32, n. 10, p. 2049, doi. 10.1177/09622802231192955

By:

Zhang, Jingyi;
Yan, Fangrong;
Wages, Nolan A;
Lin, Ruitao

Publication type:

Article

A unified Bayesian framework for exact inference of area under the receiver operating characteristic curve.

Published in:

Statistical Methods in Medical Research, 2021, v. 30, n. 10, p. 2269, doi. 10.1177/09622802211037070

By:

Lin, Ruitao;
Chan, KC Gary;
Shi, Haolun

Publication type:

Article

Comparative review of novel model‐assisted designs for phase I/II clinical trials.

Published in:

Biometrical Journal, 2024, v. 66, n. 4, p. 1, doi. 10.1002/bimj.202300398

By:

Shi, Haolun;
Lin, Ruitao;
Lin, Xiaolei

Publication type:

Article

A generalized calibrated Bayesian hierarchical modeling approach to basket trials with multiple endpoints.

Published in:

Biometrical Journal, 2024, v. 66, n. 2, p. 1, doi. 10.1002/bimj.202300122

By:

Chi, Xiaohan;
Yuan, Ying;
Yu, Zhangsheng;
Lin, Ruitao

Publication type:

Article

TOP: Time-to-Event Bayesian Optimal Phase II Trial Design for Cancer Immunotherapy.

Published in:

2020

By:

Lin, Ruitao;
Coleman, Robert L;
Yuan, Ying

Publication type:

journal article

A novel statistical method for decontaminating T-cell receptor sequencing data.

Published in:

Briefings in Bioinformatics, 2023, v. 24, n. 4, p. 1, doi. 10.1093/bib/bbad230

By:

Li, Ruoxing;
Altan, Mehmet;
Reuben, Alexandre;
Lin, Ruitao;
Heymach, John V;
Tran, Hai;
Chen, Runzhe;
Little, Latasha;
Hubert, Shawna;
Zhang, Jianjun;
Li, Ziyi

Publication type:

Article

Bayesian sequential monitoring strategies for trials of digestive cancer therapeutics.

Published in:

BMC Medical Research Methodology, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12874-024-02278-3

By:

Mulier, Guillaume;
Lin, Ruitao;
Aparicio, Thomas;
Biard, Lucie

Publication type:

Article